Prostate cancer. Gleason 4+3, PSA = 17.6.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Your Prostate Cancer Results
Thank you for sharing this information. Let me help you understand what these findings mean so you can have more informed conversations with your care team.
What Your Results Tell Us
Gleason Score 4+3: Your Gleason score describes how the cancer cells look under a microscope compared to normal prostate cells. The score ranges from 2-10, where higher numbers mean the cancer cells look more abnormal.
- Your score of 4+3 means the most common pattern is Grade 4 (moderately abnormal) and the second most common is Grade 3 (slightly abnormal)
- This is considered intermediate to higher-risk disease based on NCCN Guidelines
- The Gleason score helps predict how quickly the cancer might grow
PSA Level of 17.6 ng/mL: PSA (prostate-specific antigen) is a protein made by the prostate. According to NCCN Guidelines, PSA levels help assess your cancer risk:
- A PSA of 17.6 is elevated (normal is typically under 4.0 ng/mL)
- Combined with your Gleason score, this suggests intermediate-to-higher risk disease
- PSA helps your doctors understand the extent of cancer and plan treatment
What Doctors Consider Next
According to NCCN Guidelines for Early-Stage Prostate Cancer, your care team will likely evaluate:
- Tumor stage (TNM staging) - Whether cancer is confined to the prostate or has spread to lymph nodes or distant areas
- Biopsy results - How many core samples contained cancer and where it's located in the prostate
- Your overall risk group - Combining PSA, Gleason score, tumor stage, and biopsy findings to determine treatment options
Treatment Approaches That Typically Apply
For patients with intermediate-to-higher risk prostate cancer like yours, NCCN Guidelines generally describe several options:
- Active surveillance - Frequent monitoring with PSA tests and imaging if you choose to delay treatment
- Radiation therapy - Often combined with hormone therapy (androgen deprivation therapy/ADT)
- Surgery - Radical prostatectomy (removal of the prostate and surrounding tissue)
- Hormone therapy - May be used alone or combined with other treatments to block testosterone that fuels cancer growth
Important Questions to Ask Your Oncologist
Since your specific situation requires your doctor's complete evaluation, here are key questions to discuss:
- What is my complete TNM stage, and what does that mean for my prognosis?
- What is my risk group classification, and how does that affect treatment options?
- Do you recommend surgery, radiation, active surveillance, or another approach—and why?
- If hormone therapy is recommended, how long would I take it, and what side effects should I expect?
- Are there any clinical trials appropriate for my specific situation?
- What imaging or additional testing do you recommend before we finalize a treatment plan?
Next Steps
Your oncologist will determine the most appropriate approach for YOUR case based on:
- Complete staging information
- Your age and overall health
- Your preferences and life expectancy
- The complete clinical picture
According to NCCN Guidelines, it's important to bring someone with you to appointments to listen, ask questions, and take notes. Don't hesitate to ask for clarification on anything you don't understand.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ